Most Viewed Articles - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Most Viewed Articles

Eli Lilly Receives $1.3 Billion Following Bristol-Myers Squibb's Acquisition of Amylin Pharmaceuticals

August 22, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Eli Lilly has received $1.3 billion for payment of financial obligations from Amylin Pharmaceuticals following Bristol-Myers Squibb's acquisition of Amylin Pharmaceuticals earlier this month.

Grey-Market Distributor Convicted of Defrauding FDA

August 20, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

South Carolina-based Altec Medical pleaded guilty to one count of conspiring to defraud FDA and to commit federal offenses in connection with a drug-diversion scheme that lasted from 2007 to 2009.

AstraZeneca and Bristol-Myers Squibb Extend Diabetes Alliance

August 13, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

AstraZeneca has paid approximately $3.2 billion to extend its diabetes alliance with Bristol-Myers Squibb (BMS), following BMS's recently completed acquisition of Amylin Pharmaceuticals.

Elan to Spin Off Discovery Sciences

August 13, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Elan Corporation announced plans to spin off its discovery unit and Neotope Biosciences division to create an independent entity focused on R&D.

Pfizer Settles with DOJ and SEC on Improper Conduct in Select Emerging Markets

August 7, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

An internal investigation and voluntary disclosure by Pfizer led to a settlement with the US Department of Justice and Securities and Exchange Commission.

Carbon Measurement Methods for Cleaning Validation (Peer Reviewed)

August 2, 2012

Pharmaceutical Technology

The authors compare direct combustion with rinse and swab sampling methods.

Measuring Growth in Big Pharma's Manufacturing Investment

August 2, 2012

Pharmaceutical Technology

Pharmaceutical Technology's annual manufacturing investment update shows slight gains in biopharmaceutical manufacturing and emerging markets and continued restructuring of supply networks.

Pharmaceutical-Based Cargo Security and Theft Prevention

August 2, 2012

Pharmaceutical Technology

The author discusses strategies for preventing cargo theft.

Drug Delivery Insights: Nanotechnology and Microspheres

August 1, 2012

PTSM: Pharmaceutical Technology Sourcing and Management

Nanolipogels for anticancer drug delivery, inhalable and thermo-responsive, fat-encased nanoparticles for targeted drug delivery, and calcium carbonate microspheres are some recent developments.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here